54 related articles for article (PubMed ID: 16454695)
1. Topotecan is a substrate for multidrug resistance associated protein 4.
Tian Q; Zhang J; Chan SY; Tan TM; Duan W; Huang M; Zhu YZ; Chan E; Yu Q; Nie YQ; Ho PC; Li Q; Ng KY; Yang HY; Wei H; Bian JS; Zhou SF
Curr Drug Metab; 2006 Jan; 7(1):105-18. PubMed ID: 16454695
[TBL] [Abstract][Full Text] [Related]
2. Novel Symmetrical Cage Compounds as Inhibitors of the Symmetrical MRP4-Efflux Pump for Anticancer Therapy.
Kreutzer D; Döring H; Werner P; Ritter CA; Hilgeroth A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065900
[TBL] [Abstract][Full Text] [Related]
3. Structural and mechanistic basis of substrate transport by the multidrug transporter MRP4.
Bloch M; Raj I; Pape T; Taylor NMI
Structure; 2023 Nov; 31(11):1407-1418.e6. PubMed ID: 37683641
[TBL] [Abstract][Full Text] [Related]
4. Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents.
Lee J; Kang J; Kwon NY; Sivaraman A; Naik R; Jin SY; Oh AR; Shin JH; Na Y; Lee K; Lee HJ
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33921129
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells.
Yanar S; Kanli A; Kasap M; Bal Albayrak MG; Eskiler GG; Ozkan AD
Mol Biol Rep; 2024 Jan; 51(1):145. PubMed ID: 38236451
[TBL] [Abstract][Full Text] [Related]
6. A Camptothetin Analog, Topotecan, Promotes HIV Latency via Interference with HIV Transcription and RNA Splicing.
Mukim A; Smith DM; Deshmukh S; Qazi AA; Beliakova-Bethell N
J Virol; 2023 Feb; 97(2):e0163022. PubMed ID: 36719238
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850).
Kimura T; Okada K; Morohashi Y; Kato Y; Mori M; Kato H; Matsumoto T; Shimoyama S
Pharm Res; 2024 Apr; 41(4):795-806. PubMed ID: 38536615
[TBL] [Abstract][Full Text] [Related]
8. Effect of the combined binding of topotecan and catechin/protocatechuic acid to a pH-sensitive DNA tetrahedron on release and cytotoxicity: Spectroscopic and calorimetric studies.
Wang L; Liu J; Wang X; Li X; Zhang X; Yuan L; Wu Y; Liu M
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124179. PubMed ID: 38522375
[TBL] [Abstract][Full Text] [Related]
9. Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3.
Sun HJ; Xiong SP; Cao X; Cao L; Zhu MY; Wu ZY; Bian JS
Redox Biol; 2021 Jan; 38():101813. PubMed ID: 33279869
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors.
Madkour MM; Ramadan WS; Saleh E; El-Awady R
Ann Med; 2023 Dec; 55(1):2203946. PubMed ID: 37092854
[TBL] [Abstract][Full Text] [Related]
11. Establishment and Validation of a Peroxisome-related Gene Signature for Prognostic Prediction and Immune Distinction in Hepatocellular Carcinoma.
Miao D; Xu Q; Zeng Y; Zhao R; Song X; Chen Z; Zeng L; Zhao L; Lin Z; Yu F
J Cancer; 2022; 13(5):1418-1435. PubMed ID: 35371321
[No Abstract] [Full Text] [Related]
12. Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach.
Haque A; Baig GA; Alshawli AS; Sait KHW; Hafeez BB; Tripathi MK; Alghamdi BS; Mohammed Ali HSH; Rasool M
Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330134
[TBL] [Abstract][Full Text] [Related]
13. Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan.
Rosa-Teijeiro C; Wagner V; Corbeil A; d'Annessa I; Leprohon P; do Monte-Neto RL; Fernandez-Prada C
Parasit Vectors; 2021 Aug; 14(1):438. PubMed ID: 34454601
[TBL] [Abstract][Full Text] [Related]
14. Choroid Plexus and Drug Removal Mechanisms.
Sun A; Wang J
AAPS J; 2021 May; 23(3):61. PubMed ID: 33942198
[TBL] [Abstract][Full Text] [Related]
15. A Human ABC Transporter ABCC4 Gene SNP (rs11568658, 559 G > T, G187W) Reduces ABCC4-Dependent Drug Resistance.
Tsukamoto M; Yamashita M; Nishi T; Nakagawa H
Cells; 2019 Jan; 8(1):. PubMed ID: 30634695
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening.
Chen Y; Yuan X; Xiao Z; Jin H; Zhang L; Liu Z
PLoS One; 2018; 13(10):e0205175. PubMed ID: 30321196
[TBL] [Abstract][Full Text] [Related]
17. Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine.
Nicolaï J; Thevelin L; Bing Q; Stieger B; Chanteux H; Augustijns P; Annaert P
Pharm Res; 2017 Nov; 34(11):2336-2348. PubMed ID: 28828541
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4.
Tsukamoto M; Sato S; Satake K; Miyake M; Nakagawa H
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677646
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier.
Kanamitsu K; Kusuhara H; Schuetz JD; Takeuchi K; Sugiyama Y
J Pharm Sci; 2017 Sep; 106(9):2566-2575. PubMed ID: 28456721
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance-associated protein 4 is a determinant of arsenite resistance.
Yuan B; Yoshino Y; Fukushima H; Markova S; Takagi N; Toyoda H; Kroetz DL
Oncol Rep; 2016 Jan; 35(1):147-54. PubMed ID: 26497925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
